KCNQ1

KCNQ1 Full Name

potassium voltage-gated channel, KQT-like subfamily, member 1

KCNQ1 Introduction

The KCNQ1 (potassium voltage-gated channel subfamily Q member 1) gene encodes a pore-forming alpha subunit that assembles to create one of the most important potassium channels in the human body. Known historically by several synonyms including KvLQT1, Kv7.1, and KCNA8, this gene was first identified through positional cloning efforts aimed at understanding the genetic causes of life-threatening cardiac arrhythmias. Since its discovery, KCNQ1 has emerged as a remarkably versatile channel with critical functions spanning the heart, inner ear, stomach, intestines, and multiple other organ systems. Its ability to interact with different accessory subunits (particularly KCNE family members) allows a single pore-forming protein to generate currents with vastly different properties tailored to specific physiological contexts. The clinical importance of KCNQ1 is underscored by its association with an extraordinary spectrum of disorders—mutations can cause long QT syndrome (both dominant and recessive forms), short QT syndrome, familial atrial fibrillation, and have been implicated in type 2 diabetes susceptibility and cancer progression.

Figure 1. KCNQ1 potassium ion channel.(Dixit G, 2020)

Protein Structure and Channel Assembly
KCNQ1 encodes a protein that functions as a voltage-gated potassium channel alpha subunit, characterized by a conserved six-transmembrane domain (S1-S6) topology with a single pore-loop region. The S4 transmembrane segment serves as the voltage sensor, containing positively charged amino acids that respond to changes in membrane potential by moving within the electric field and initiating conformational changes that open the channel pore. Four KCNQ1 subunits assemble as a tetramer to form a functional channel, with the pore loops from each subunit contributing to the ion selectivity filter that permits passage of potassium ions while excluding sodium and other cations.

Conclusion
KCNQ1 stands as a paradigmatic example of how a single gene can generate remarkable functional diversity through alternative splicing, tissue-specific expression, and modulatory interactions with accessory subunits. From its essential role in cardiac repolarization and auditory function to its emerging importance in metabolic disease and cancer, this potassium channel continues to surprise and inform our understanding of human physiology and disease. The clinical spectrum associated with KCNQ1 mutations—spanning lethal cardiac arrhythmias, congenital deafness, diabetes susceptibility, and cancer progression—underscores the fundamental importance of potassium homeostasis in virtually every organ system. As research continues to unravel the complex regulatory networks governing KCNQ1 expression and function, new therapeutic opportunities are emerging, including repurposing existing drugs such as calcium channel antagonists for JLNS and developing KCNQ channel modulators for cancer treatment. The journey from its initial discovery as a long QT syndrome gene to its current status as a multi-system regulator exemplifies the power of human genetics to illuminate fundamental biology and guide precision medicine.

Alternate Names for KCNQ1

KCNQ1; potassium voltage-gated channel, KQT-like subfamily, member 1; LQT; RWS; WRS; LQT1; SQT2; ATFB1; ATFB3; JLNS1